Hui Wang is a seasoned professional in the field of Oncology, currently serving as Director at Incyte since February 2023, following a prior role as Executive Director at Synnovation Therapeutics. Wang has extensive experience in leading small molecule Oncology programs at Incyte, with previous positions including Associate Director and Senior Research Investigator, where expertise was demonstrated in Immune Oncology and combination therapies. Prior experience includes postdoctoral research at the Novartis Institute for BioMedical Research with significant discoveries related to the Hippo-YAP pathway and a postdoc fellowship at Duke University Medical Center focusing on MicroRNA's role in brain tumors. Hui Wang earned a Ph.D. in Pharmacology from Duke University and holds a BS in Biological Science from Tsinghua University.
This person is not in any teams
This person is not in any offices